ENvue Medical (FEED) Cash from Operations Growth (1y) (2015 - 2026)
ENvue Medical (FEED) Cash from Operations Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn | -12.60% |
| 10 | ENvue Medical | 2.51 Mn | 1.37 Mn | -266,000.00 | 20.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.46% |
| Mar 31, 2026 | -221.07% |
| Dec 31, 2025 | -388.32% |
| Sep 30, 2025 | -135.65% |
| Jun 30, 2025 | -511.75% |
| Mar 31, 2025 | -131.95% |
| Dec 31, 2024 | -11.61% |
| Sep 30, 2024 | -22.58% |
| Jun 30, 2024 | 55.00% |
| Mar 31, 2024 | 51.75% |
| Dec 31, 2023 | 63.11% |
| Sep 30, 2023 | 65.27% |
| Jun 30, 2023 | 38.52% |
| Mar 31, 2023 | 31.07% |
| Dec 31, 2022 | -54.23% |
| Sep 30, 2022 | -209.78% |
| Jun 30, 2022 | -4.33% |
| Mar 31, 2022 | -82.49% |
| Dec 31, 2021 | 34.52% |
| Sep 30, 2021 | 8.78% |